| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23f3f5b328be6633c9d12263d7f42d02 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y115-01001 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-446
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1767 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06 |
| filingDate |
2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10decfe096ebafd2fb9cc1f01e996e4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9ec333a9f1f1e0e761ef44d721adee2 |
| publicationDate |
2019-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201929877-A |
| titleOfInvention |
Use of didar protein for the manufacture of a pharmaceutical composition for protecting brain cells |
| abstract |
The present invention relates to the use of a diloprotein, and provides the use of diloprotein for the manufacture of a pharmaceutical composition for protecting brain nerve cells. The pharmaceutical composition can improve the performance of antioxidant genes in nerve cells, or inhibit beta The effects of amyloid protein (A-β) and 1-methyl-4-phenyl-phenylpyridinium (MPP + ) on nerve cells, which reduce the damage to brain nerve cells . |
| priorityDate |
2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |